Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults

• Stéphane Pillet,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliations Medicago Inc., Québec City, Québec, Canada, Research Institute, McGill University Health Centre, Montreal, Québec, Canada

  ⨯
• Julie Couillard,

  Roles Data curation, Formal analysis, Writing – original draft

  Affiliation Medicago Inc., Québec City, Québec, Canada

  ⨯
• Sonia Trépanier,

  Roles Methodology, Project administration, Supervision, Writing – review & editing

  Affiliation Medicago Inc., Québec City, Québec, Canada

  ⨯
• Jean-François Poulin,

  Roles Data curation, Formal analysis, Validation

  Affiliation Caprion Biosciences Inc., Montréal, Québec, Canada

  ⨯
• Bader Yassine-Diab,

  Roles Data curation, Formal analysis, Validation

  Affiliation Caprion Biosciences Inc., Montréal, Québec, Canada

  ⨯
• Bruno Guy,

  Roles Investigation, Writing – original draft

  Affiliation Expert/Consultant–Microbiology and Vaccinology, Lyon, France

  ⨯
• Brian J. Ward,

  Roles Conceptualization, Investigation, Project administration, Writing – review & editing

  Affiliations Medicago Inc., Québec City, Québec, Canada, Research Institute, McGill University Health Centre, Montreal, Québec, Canada

  ⨯
• Nathalie Landry

  Roles Conceptualization, Investigation, Supervision, Writing – review & editing

  * E-mail: landryn@medicago.com

  Affiliation Medicago Inc., Québec City, Québec, Canada

  http://orcid.org/0000-0003-3500-0484

  ⨯